ArticleChemical science2026
Photocatalytic synthesis of phosphorothioates by sulfur transfer from thiosulfate.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With therapeutic oligonucleotides progressing from the treatment of rare genetic diseases to the medication of common disorders, the synthesis of modified oligonucleotides is gaining considerable significance. To improve pharmacokinetic and pharmacodynamic properties, chemical modifications to the nucleotide backbone are thereby especially advantageous. In particular, the incorporation of phosphorothioate moieties has proven to be an effective strategy, since this linkage often provides increased metabolic stability and beneficial activity compared to phosphates. Herein, we describe that visible-light photocatalysis allows the generation of phosphorothioates by an exceptionally mild and general sulfurization with conventional thiosulfate as a benign sulfur source. The method was applied to efficiently prepare DNA and RNA phosphorothioates, phosphoramidothioate, phosphine sulfides and phosphoramidodithioate. Furthermore, the protocol was translated to the synthesis of phosphoroselenoates using selenosulfate and was integrated into standard solid-phase phosphoramidite oligonucleotide synthesis to form phosphorothioates with riboflavin (vitamin B2) as a photocatalyst in water, representing a sustainable means for the synthesis of DNA and RNA phosphorothioates.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.